Connect with us
[bsa_pro_ad_space id=12]

Business

From ‘brilliant’ to ‘aghast’: Reactions to RFK Jr.’s nomination for HHS secretary run the gamut

Published

12 minute read

From LifeSiteNews

By Dr. Brenda Baletti, The Defender

From “brilliant” to “aghast” – President-elect Donald J. Trump’s nomination on Thursday of Robert F. Kennedy Jr., founder of Children’s Health Defense (CHD), to run the U.S. Department of Health and Human Services (HHS) triggered a range of reactions among media outlets, public health officials, and Kennedy’s long-time supporters and detractors.

In a statement posted on Truth Social and X, Trump said Kennedy would restore the public health agencies “to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!”

Kennedy, who promised to fight corruption and end the revolving door between industry and government, thanked Trump for the nomination on social media. He said he would “free the agencies from the smothering cloud of corporate capture so they can pursue their mission to make Americans once again the healthiest people on Earth.”

 

Kennedy is a longtime critic of how corporate interests have captured the public health agencies meant to regulate them, and of the outsized and corrupt role that Big Pharma plays in American life.

If confirmed, Kennedy would hold the most powerful governmental position in public health, overseeing 80,000 employees across a department that houses 13 agencies and more than 100 programs. Those agencies include the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), the National Institutes of Health and the Center for Medicaid and Medicare Services.

CHD CEO Mary Holland told The Defender the organization “could not be more pleased” with the nomination, adding:

Kennedy has been devoted to ending the childhood chronic health epidemic for almost 20 years. He has been effective in communicating the failures of our existing public health establishment.

Based on his extensive litigation history, he is uniquely prepared to reform the regulatory institutions, the research institutions, and public education on health. I look forward to seeing dramatic, measurable improvements in Americans’ health during the Trump administration.

Democratic Colorado Gov. Jared Polis said on X that he was “excited by the news,” particularly about Kennedy’s commitment to fighting chemicals in foods, the power of Big Pharma, and to other health priorities.

“I hope he leans into personal choice on vaccines rather than bans (which I think are terrible, just like mandates) but what I’m most optimistic about is taking on big pharma and the corporate ag oligopoly to improve our health,” he added.

Rep. Chip Roy (R-Texas) told Fox News, “I think Robert is another disruptor. We need a disruptor. I will be glad and I’m looking forward to working with him,” Politico reported.

Sen. Ron Johnson (R-Wis.) called Kennedy a “brilliant, courageous truth-teller” and said he could make the “most significant impact on health.”

Vaccine stocks take a dive on news of announcement

On the flip side, some lawmakers and public health leaders expressed alarm, decrying the nomination.

U.S. Rep. Robert Garcia (D-Calif.) called the choice “f— insane” on X, Fox News reported. “He’s a vaccine denier and a tin foil hat conspiracy theorist. He will destroy our public health infrastructure and our vaccine distribution systems. This is going to cost lives.”

Dr. Richard E. Besser, CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, said that having Kennedy head up HHS “would pose incredible risks to the health of the nation,” because Kennedy’s critique of the public health agencies was worsening the mistrust lingering after the coronavirus pandemic, The New York Times reported.

Besser told CNN that some of Kennedy’s ideas about chronic health issues regarding children were good ideas, but other ideas were deeply concerning – particularly Kennedy’s proposal that individuals should decide for themselves whether to take a vaccine.

“The idea that receiving childhood vaccines would be a parental choice scares me,” he said.

READ: Canada’s public health agency still working to adopt WHO pandemic treaty: report

Current CDC Director Mandy Cohen raised concerns that Kennedy would use the position to spread misinformation and foster distrust in public health institutions, particularly with respect to vaccines.

Kennedy has called for an end to immunity for vaccine manufacturers for the injuries caused by their products. He points out that no vaccine on the childhood immunization schedule has undergone proper safety and efficacy testing.

He has been a long-term advocate for the tens of thousands of families seeking compensation for their children’s vaccine-induced autism.

Kennedy also promised that, if confirmed, he would make the V-safe vaccine injury data collected but not made public by the CDC transparent, so scientists have access to the data necessary to analyze vaccine safety

Vaccine and Pharma stocks fell sharply this morning, following yesterday’s announcement about Kennedy, Reuters reported.

 

Bavarian Nordic, which makes the mpox vaccine, was down 16 percent. Its CEO told Reuters he was concerned that Kennedy could fuel vaccine skepticism.

However, he also said that the U.S. response to the COVID-19 pandemic under Trump’s first term made him confident that the incoming administration would continue to fund biodefense.

The Trump administration launched and oversaw Operation Warp Speed, the public-private partnership to rapidly develop a COVID-19 vaccine that gave vaccine makers hundreds of billions in profits along with total immunity for any harms caused by those investigational vaccines under the Public Readiness and Emergency Preparedness (PREP) Act.

Kennedy will be ‘single greatest threat to profits in America’

Republican advisers have cautioned that Kennedy could face a difficult path to confirmation, The Washington Post reported, citing his “past statements on drugs and vaccines, and his many personal entanglements.” FiercePharma said his confirmation process is likely “to be contentious.”

Physician, professor and Substacker Dr. Vinay Prasad wrote that Trump could use a recess appointment to secure Kennedy’s position, but that he will likely need to be confirmed by the Senate where “He has a several hundred billion dollar industry that will do everything possible to stop him.”

“Many of these companies have lobbied throughout Congress,” Prasad added. “They will use those connections. Unlike other controversial appointees, RFK Jr. will be the single greatest threat to profits in America.”

If his appointment goes through, Prasad said Kennedy will face a difficult road in getting his proposed policies enacted, given the entrenched power of Pharma and the power of the media that opposes him.

Law professor Wendy Parmet, director of Northeastern University’s Center for Health Policy and Law, pointed to the potential clash between Kennedy’s anti-industry position and the big-business leanings of the Republican Party.

“We have an administration that promises to deregulate, to be business-friendly, and then we have RFK Jr., who promises to go after fast food,” Parmet told The Washington Post.

READ: Idaho health district votes to stop offering COVID vaccines at its medical centers

Health and health freedom advocates optimistic Kennedy will bring change

Despite the challenges ahead, health advocates are optimistic that changes they have been seeking for decades will come to pass.

During the COVID-19 pandemic, critics of pandemic policies were condemned and marginalized. Kennedy was censored by the Biden administration and social media companies as part of the so-called “Disinformation Dozen” for airing many of those critiques.

Over the course of the election Kennedy – who ran for president as a Democrat, then announced he was running as an independent before suspending his campaign and endorsing Trump – has repeatedly been called a “conspiracy theorist.” Both Kennedy and CHD are routinely dismissed as “anti-vax” for openly discussing the scientific evidence on the link between vaccines and chronic diseases including autism, attention-deficit/hyperactivity disorder or ADHD and other neuropsychiatric and autoimmune disorders, in some children.

Rather than investigating the science, mainstream media mostly insists these links have been “debunked,” without providing any evidence for their claim.

Kennedy has also called for the removal of fluoride from public drinking water, citing recent studies and a landmark federal court decision that show it interferes with children’s brain development – a concern that has even been flagged by some mainstream public health commentators.

His supporters hope these issues will now receive serious public attention that will lead to policy change.

Holland said on X that Kennedy’s nomination came 38 years to the day after the Vaccine Injury Act that gave vaccine manufacturers immunity from liability was signed into law.

Let’s rewrite this one,” she said.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Alberta

Emissions Reduction Alberta offering financial boost for the next transformative drilling idea

Published on

From the Canadian Energy Centre

$35-million Alberta challenge targets next-gen drilling opportunities

‘All transformative ideas are really eligible’

Forget the old image of a straight vertical oil and gas well.

In Western Canada, engineers now steer wells for kilometres underground with remarkable precision, tapping vast energy resources from a single spot on the surface.

The sector is continually evolving as operators pursue next-generation drilling technologies that lower costs while opening new opportunities and reducing environmental impacts.

But many promising innovations never reach the market because of high development costs and limited opportunities for real-world testing, according to Emissions Reduction Alberta (ERA).

That’s why ERA is launching the Drilling Technology Challenge, which will invest up to $35 million to advance new drilling and subsurface technologies.

“The focus isn’t just on drilling, it’s about building our future economy, helping reduce emissions, creating new industries and making sure we remain a responsible leader in energy development for decades to come,” said ERA CEO Justin Riemer.

And it’s not just about oil and gas. ERA says emerging technologies can unlock new resource opportunities such as geothermal energy, deep geological CO₂ storage and critical minerals extraction.

“Alberta’s wealth comes from our natural resources, most of which are extracted through drilling and other subsurface technologies,” said Gurpreet Lail, CEO of Enserva, which represents energy service companies.

ERA funding for the challenge will range from $250,000 to $8 million per project.

Eligible technologies include advanced drilling systems, downhole tools and sensors; AI-enabled automation and optimization; low-impact rigs and fluids; geothermal and critical mineral drilling applications; and supporting infrastructure like mobile labs and simulation platforms.

“All transformative ideas are really eligible for this call,” Riemer said, noting that AI-based technologies are likely to play a growing role.

“I think what we’re seeing is that the wells of the future are going to be guided by smart sensors and real-time data. You’re going to have a lot of AI-driven controls that help operators make instant decisions and avoid problems.”

Applications for the Drilling Technology Challenge close January 29, 2026.

Continue Reading

armed forces

Global Military Industrial Complex Has Never Had It So Good, New Report Finds

Published on

 

From the Daily Caller News Foundation

By Wallace White

The global war business scored record revenues in 2024 amid multiple protracted proxy conflicts across the world, according to a new industry analysis released on Monday.

The top 100 arms manufacturers in the world raked in $679 billion in revenue in 2024, up 5.9% from the year prior, according to a new Stockholm International Peace Research Institute (SIPRI) study. The figure marks the highest ever revenue for manufacturers recorded by SIPRI as the group credits major conflicts for supplying the large appetite for arms around the world.

“The rise in the total arms revenues of the Top 100 in 2024 was mostly due to overall increases in the arms revenues of companies based in Europe and the United States,” SIPRI said in their report. “There were year-on-year increases in all the geographical areas covered by the ranking apart from Asia and Oceania, which saw a slight decrease, largely as a result of a notable drop in the total arms revenues of Chinese companies.”

Notably, Chinese arms manufacturers saw a large drop in reported revenues, declining 10% from 2023 to 2024, according to SIPRI. Just off China’s shores, Japan’s arms industry saw the largest single year-over-year increase in revenue of all regions measured, jumping 40% from 2023 to 2024.

American companies dominate the top of the list, which measures individual companies’ revenue, with Lockheed Martin taking the top spot with $64,650,000,000 of arms revenue in 2024, according to the report. Raytheon Technologies, Northrop Grumman and BAE Systems follow shortly after in revenue,

The Czechoslovak Group recorded the single largest jump in year-on-year revenue from 2023 to 2024, increasing its haul by 193%, according to SIPRI. The increase is largely driven by their crucial role in supplying arms and ammunition to Ukraine.

The Pentagon contracted one of the group’s subsidiaries in August to build a new ammo plant in the U.S. to replenish artillery shell stockpiles drained by U.S. aid to Ukraine.

“In 2024 the growing demand for military equipment around the world, primarily linked to rising geopolitical tensions, accelerated the increase in total Top 100 arms revenues seen in 2023,” the report reads. “More than three quarters of companies in the Top 100 (77 companies) increased their arms revenues in 2024, with 42 reporting at least double-digit percentage growth.”

Continue Reading

Trending

X